Targeted Angiogenesis Therapy in Head and Neck Squamous Cell Carcinomas

Publisher： Bentham Science Publishers

E-ISSN： 2211-5536|1|1|26-38

ISSN： 2211-5528

Source： Current Angiogenesis, Vol.1, Iss.1, 2012-04, pp. : 26-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular-targeted therapy hypoxia in head and neck squamous cell carcinoma patients (Review)

By Adachi   Thomas  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-14

Spandidos Publications

Access to resources Recommend Favorite

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

By Hadden J.   Verastegui E.   Barrera J.L.   Kurman M.   Meneses A.   Zinser J.W.   de la Garza J.   Hadden E.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1073-1081

Elsevier

Access to resources Recommend Favorite

Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma

By            

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 918-924

Spandidos Publications

Access to resources Recommend Favorite

Ovarian Cancer - Angiogenesis and Targeted Therapy

By  

Current Angiogenesis, Vol. 3, Iss. 4, 2014-01 ,pp. : 215-230

Bentham Science Publishers

Access to resources Recommend Favorite

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

By Lathers D.M.R.   Achille N.J.   Young M.R.I.  

Human Immunology, Vol. 64, Iss. 12, 2003-12 ,pp. : 1160-1166

Elsevier

Access to resources Recommend Favorite